PT3003327T - Polímeros de ligação de protões para administração oral - Google Patents

Polímeros de ligação de protões para administração oral

Info

Publication number: PT3003327T
Authority: PT; Portugal
Prior art keywords: proton; oral administration; binding polymers; polymers; binding
Prior art date: 2013-06-05

Application number

PT147420012T

Other languages

English (en)

Inventor

Klaerner Gerrit

F Connor Eric

K Gbur Randi

J Kade Matthew

H Kierstead Paul

M Buysse Jerry

J Cope Michael

N Biyani Kalpesh

H Nguyen Son

M Tabakman Scott

Original Assignee

Tricida Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-06-05

Filing date

2014-06-05

Publication date

2017-11-09

2014-06-05 Application filed by Tricida Inc filed Critical Tricida Inc

2017-11-09 Publication of PT3003327T publication Critical patent/PT3003327T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/024—Polyamines containing oxygen in the form of ether bonds in the main chain
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
- G01N2001/4083—Concentrating samples by other techniques involving separation of suspended solids sedimentation
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
- G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Pathology (AREA)
Immunology (AREA)
General Physics & Mathematics (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

PT147420012T 2013-06-05 2014-06-05 Polímeros de ligação de protões para administração oral PT3003327T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201361831445P	2013-06-05	2013-06-05

Publications (1)

Publication Number	Publication Date
PT3003327T true PT3003327T (pt)	2017-11-09

Family

ID=51212941

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PT191692599T PT3578185T (pt)	2013-06-05	2014-06-05	Polímeros ligantes de protões para administração oral
PT147420012T PT3003327T (pt)	2013-06-05	2014-06-05	Polímeros de ligação de protões para administração oral
PT17177221T PT3287133T (pt)	2013-06-05	2014-06-05	Polímeros ligantes de protões para administração oral

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT191692599T PT3578185T (pt)	2013-06-05	2014-06-05	Polímeros ligantes de protões para administração oral

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT17177221T PT3287133T (pt)	2013-06-05	2014-06-05	Polímeros ligantes de protões para administração oral

Country Status (26)

Country	Link
US (8)	US9205107B2 (pt)
EP (4)	EP3287133B1 (pt)
JP (5)	JP6453860B2 (pt)
KR (5)	KR102717667B1 (pt)
CN (3)	CN111671766B (pt)
AU (3)	AU2014274817B2 (pt)
BR (1)	BR112015030142B1 (pt)
CA (1)	CA2912911C (pt)
CY (3)	CY1119611T1 (pt)
DK (3)	DK3287133T3 (pt)
ES (3)	ES2834485T3 (pt)
HK (1)	HK1251151B (pt)
HR (3)	HRP20171590T1 (pt)
HU (3)	HUE034836T2 (pt)
IL (3)	IL242758B (pt)
LT (3)	LT3287133T (pt)
MX (3)	MX364785B (pt)
NO (1)	NO2905572T3 (pt)
PL (2)	PL3287133T3 (pt)
PT (3)	PT3578185T (pt)
RS (2)	RS59033B1 (pt)
RU (1)	RU2728778C2 (pt)
SI (3)	SI3578185T1 (pt)
SM (2)	SMT202000596T1 (pt)
TR (1)	TR201909355T4 (pt)
WO (1)	WO2014197725A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6453860B2 (ja) *	2013-06-05	2019-01-16	トリシダ・インコーポレイテッドＴｒｉｃｉｄａ，Ｉｎｃ．	経口投与用プロトン結合ポリマー
ME03783B (me) *	2014-12-10	2021-04-20	Tricida Inc	Polimeri koji vezuju protone za oralnu primjenu
MA44875A (fr) *	2016-05-06	2019-03-13	Tricida Inc	Compositions pour le traitement de troubles acido-basiques
EP3564292B1 (en)	2016-12-28	2021-06-16	FUJIFILM Corporation	Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles
US10934380B1 (en)	2017-09-25	2021-03-02	Tricida, Inc.	Crosslinked poly(allylamine) polymer pharmaceutical compositions
CN111225674A (zh)	2017-10-16	2020-06-02	富士胶片株式会社	高磷血症治疗剂
WO2019090177A1 (en) *	2017-11-03	2019-05-09	Tricida, Inc.	Method of treating acid-base disorders
EP3703706A4 (en)	2017-11-03	2022-04-27	Tricida Inc.	COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-BASED DISORDERS
MA51628A (fr) *	2018-06-04	2021-03-17	Tricida Inc	Méthode de traitement de troubles de l'équilibre acido-basique
EP3999593A1 (en) *	2019-07-19	2022-05-25	Acatechol, Inc.	Molecularly well-defined antibiofouling and polyionic coatings
CN117295503A (zh)	2021-03-01	2023-12-26	雷诺西斯公司	交联聚(烯丙胺)聚合物药物组合物
FI4053179T3 (fi)	2021-03-01	2025-11-26	Renosis Inc	Silloitettujen poly(allyyliamiini)polymeerien lääkekoostumuksia
CN118510524A (zh) *	2021-12-14	2024-08-16	上海石趣医药科技有限公司	氧化银和/或其水合物在制备药物中的用途
CN115260355A (zh) *	2022-05-16	2022-11-01	江苏中天药业有限公司	一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂
KR20240128205A (ko)	2023-02-17	2024-08-26	주식회사 쓰리디코리아	손잡이가 있는 운동기구용 개인별 맞춤형 그립 제조방법 및 그로써 제조된 개인별 맞춤형 그립
KR102902381B1 (ko)	2023-03-21	2025-12-23	지니에듀테크 주식회사	개인별 맞춤형 그립 형상이 형성된 운동기구용 손잡이
CN117164854A (zh) *	2023-07-07	2023-12-05	中国科学院长春应用化学研究所	一种交联型聚酰亚胺及其制备方法

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6444221B1 (en)	1992-06-30	2002-09-03	Howard K. Shapiro	Methods of treating chronic inflammatory diseases using carbonyl trapping agents
US20050090553A1 (en)	1992-06-30	2005-04-28	Shapiro Howard K.	Compositions and method for treatment of chronic inflammatory diseases
US5534259A (en) *	1993-07-08	1996-07-09	Liposome Technology, Inc.	Polymer compound and coated particle composition
US5496545A (en)	1993-08-11	1996-03-05	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
US5667775A (en)	1993-08-11	1997-09-16	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
US5648355A (en)	1994-02-09	1997-07-15	Kos Pharmaceutical, Inc.	Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
TW474813B (en)	1994-06-10	2002-02-01	Geltex Pharma Inc	Alkylated composition for removing bile salts from a patient
AU703842B2 (en)	1994-10-17	1999-04-01	Robert M. Bersin	Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
US20020006899A1 (en)	1998-10-06	2002-01-17	Pospisilik Andrew J.	Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
US5753706A (en)	1996-12-16	1998-05-19	Hsu; Chen Hsing	Methods for treating renal failure
AUPO758297A0 (en)	1997-06-27	1997-07-24	Rowe, James Baber	Control of acidic gut syndrome
US6726905B1 (en)	1997-11-05	2004-04-27	Genzyme Corporation	Poly (diallylamines)-based phosphate binders
EP1044021B1 (en) *	1998-01-05	2009-09-23	The University of Washington	Enhanced transport using membrane disruptive agents
WO1999040990A1 (en)	1998-02-17	1999-08-19	University Of Maryland	Anion binding polymers and the use thereof
US6485703B1 (en)	1998-07-31	2002-11-26	The Texas A&M University System	Compositions and methods for analyte detection
US6271264B1 (en)	1998-12-01	2001-08-07	Geltex Pharmaceuticals, Inc.	Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
US6733780B1 (en)	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
GB9927088D0 (en)	1999-11-17	2000-01-12	Secr Defence	Use of poly(diallylamine) polymers
US6844372B2 (en)	2000-03-09	2005-01-18	Hisamitsu Pharmaceutical Co., Inc.	Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
WO2001066606A1 (en)	2000-03-09	2001-09-13	Hisamitsu Pharmaceutical Co., Inc.	Crosslinked anion-exchange resin or salt thereof
WO2001068106A1 (en)	2000-03-13	2001-09-20	Hisamitsu Pharmaceutical Co., Inc.	Preventives and/or remedies for hyperphosphatemia
JP2002028737A (ja)	2000-07-07	2002-01-29	Fujitsu Ltd	プレス打ち抜き加工方法及びプレス打ち抜き加工装置
BR0209133A (pt)	2001-04-18	2004-06-15	Genzyme Corp	Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
JP5170932B2 (ja) *	2001-04-18	2013-03-27	ジェンザイムコーポレーション	低塩形態のポリアリルアミン
TW200304813A (en)	2002-03-11	2003-10-16	Novartis Ag	Salts of organic acid
AU2004210013A1 (en)	2003-02-10	2004-08-19	Autogen Research Pty Ltd	Therapeutic molecules
TWI335218B (en)	2003-02-19	2011-01-01	Panion & Bf Biotech Inc	Ferric organic compounds, uses thereof and methods of making same
CN1540136A (zh) *	2003-10-27	2004-10-27	华东理工大学	一种评价微生物驱油能力的方法
US7608674B2 (en) *	2003-11-03	2009-10-27	Ilypsa, Inc.	Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7449605B2 (en)	2003-11-03	2008-11-11	Ilypsa, Inc.	Crosslinked amine polymers
US7385012B2 (en) *	2003-11-03	2008-06-10	Ilypsa, Inc.	Polyamine polymers
US7767768B2 (en)	2003-11-03	2010-08-03	Ilypsa, Inc.	Crosslinked amine polymers
US7335795B2 (en)	2004-03-22	2008-02-26	Ilypsa, Inc.	Crosslinked amine polymers
US7459502B2 (en) *	2003-11-03	2008-12-02	Ilypsa, Inc.	Pharmaceutical compositions comprising crosslinked polyamine polymers
WO2005065291A2 (en)	2003-12-31	2005-07-21	Genzyme Corporation	Enteric coated aliphatic amine polymer bile acid sequestrants
CA2553931A1 (en)	2004-01-29	2005-08-11	Keio University	Erythrocyte function modifying substance
US8282960B2 (en)	2004-03-30	2012-10-09	Relypsa, Inc.	Ion binding compositions
US7556799B2 (en)	2004-03-30	2009-07-07	Relypsa, Inc.	Ion binding polymers and uses thereof
US7854924B2 (en)	2004-03-30	2010-12-21	Relypsa, Inc.	Methods and compositions for treatment of ion imbalances
US7429394B2 (en)	2004-03-30	2008-09-30	Relypsa, Inc.	Ion binding compositions
US8192758B2 (en)	2004-03-30	2012-06-05	Relypsa, Inc.	Ion binding compositions
BRPI0509366B8 (pt)	2004-03-30	2021-05-25	Ilypsa Inc	composição farmacêutica, kit farmacêutico, e, uso de uma composição farmacêutica
US8399025B2 (en)	2004-06-04	2013-03-19	Board Of Regents, The University Of Texas System	Polyamine modified particles
JP2008506771A (ja)	2004-07-19	2008-03-06	エヌ．ブイ．・ヌートリシア	血糖値を調節するためのアスパルテートを使用するための調製物
DE102004035808A1 (de)	2004-07-21	2006-03-16	Kasch, Helmut, Dr.	Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
US8569277B2 (en)	2004-08-11	2013-10-29	Palo Alto Investors	Methods of treating a subject for a condition
US20070293429A1 (en)	2004-10-08	2007-12-20	Therapei Pharmaceuticals, Inc.	Vasoactive Intestinal Polypeptide Compositions
US20080214440A1 (en)	2004-10-08	2008-09-04	Forbes Medi-Tech (Research), Inc.	Vasoactive intestinal polypeptide compositions
JP2008531751A (ja) *	2004-10-13	2008-08-14	イリプサ，インコーポレイテッド	架橋アミンポリマー
US7985418B2 (en)	2004-11-01	2011-07-26	Genzyme Corporation	Aliphatic amine polymer salts for tableting
ITME20040015A1 (it)	2004-12-07	2005-03-07	Vincenzo Savica	Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
US20080312156A1 (en) *	2005-01-18	2008-12-18	Duke University	In-Situ Crosslinkable Elastin-Like Polypeptides for Defect Filling in Cartilaginous Tissue Repair
US20080200533A1 (en)	2005-07-04	2008-08-21	Ramu Krishnan	Drug or Pharmaceutical Compounds and a Preparation Thereof
KR20080037083A (ko)	2005-08-18	2008-04-29	글로보아시아 엘엘씨	약학용 등급의 유기 철 화합물, 그 용도 및 이의 제조 방법
EP1951266A2 (en)	2005-09-02	2008-08-06	Genzyme Corporation	Method for removing phosphate and polymer used therefore
CN101316601A (zh) *	2005-09-30	2008-12-03	伊立普萨公司	从哺乳动物的胃肠道选择性除去钾离子的方法和组合物
GB2446076B (en) *	2005-09-30	2010-11-24	Ilypsa Inc	Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
WO2007038801A2 (en)	2005-09-30	2007-04-05	Ilypsa, Inc.	Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
CN102600202A (zh)	2005-11-08	2012-07-25	味之素株式会社	麻醉苏醒促进剂
AR060690A1 (es)	2005-11-08	2008-07-10	Genzyme Corp	Polimeros que contienen magnesio para la hiperfosfatemia
ITMI20052461A1 (it)	2005-12-22	2007-06-23	Univ Degli Studi Milano	Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
RU2008136081A (ru)	2006-02-14	2010-03-20	Тева Фармасьютикл Индастриес Лтд. (Il)	Фармацевтические составы с алифатическими аминными полимерами и способы их производства
JP2009536246A (ja)	2006-05-05	2009-10-08	ゲンズイメコーポレーション	ホスフェート捕捉剤としてのアミン縮合重合体
US20100135950A1 (en)	2006-07-05	2010-06-03	Genzyme Corporation	Iron(II)-Containing Treatments for Hyperphosphatemia
CN101541235A (zh) *	2006-07-18	2009-09-23	基酶有限公司	胺类树状物
BRPI0715053A2 (pt) *	2006-07-18	2013-03-19	Genzyme Corp	composiÇço farmacÊutica, mÉtodo para tratar doenÇas, e, polÍmero
US8391873B2 (en)	2006-07-21	2013-03-05	Qualcomm Incorporated	Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion
AU2007281433A1 (en)	2006-08-04	2008-02-07	Nastech Pharmaceutical Company Inc.	Compositions for intranasal delivery of human insulin and uses thereof
KR20090051240A (ko)	2006-09-01	2009-05-21	유에스브이 리미티드	세벨라머 염산염의 제조방법 및 그의 제형
US7964182B2 (en) *	2006-09-01	2011-06-21	USV, Ltd	Pharmaceutical compositions comprising phosphate-binding polymer
JP2010504285A (ja) *	2006-09-01	2010-02-12	ゲンズイメコーポレーション	デンドリマー組成物
JP5427029B2 (ja)	2006-09-06	2014-02-26	スキャンポ・アーゲー	消化管の重炭酸分泌を促進するための方法および組成物
US8425887B2 (en)	2006-09-29	2013-04-23	Genzyme Corporation	Amide dendrimer compositions
EP2120972A1 (en)	2006-12-14	2009-11-25	Genzyme Corporation	Amido-amine polymer compositions
JP2010519298A (ja)	2007-02-23	2010-06-03	ゲンズイメコーポレーション	アミンポリマー組成物
US20080207766A1 (en)	2007-02-27	2008-08-28	Agi Therapeutics Research Ltd.	Methods and compositions for treating at least one upper gastrointestinal symptom
WO2008109095A1 (en)	2007-03-08	2008-09-12	Genzyme Corporation	Sulfone polymer compositions
TWI445540B (zh)	2007-04-20	2014-07-21	Ajinomoto Kk	抗低體溫組成物
WO2008133954A1 (en)	2007-04-27	2008-11-06	Genzyme Corporation	Amido-amine dendrimer compositions
US8273384B2 (en)	2007-07-02	2012-09-25	Stephen Ray Wurzberger	Process for the preparation of a non-corrosive base solution and methods of using same
WO2009008480A1 (ja) *	2007-07-11	2009-01-15	Toray Industries, Inc.	架橋ポリアリルアミン又はその酸付加塩、及びその医薬用途
EP2016947A1 (en)	2007-07-17	2009-01-21	Chemo Ibérica, S.A.	Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en)	2007-08-10	2009-02-19	Ilypsa, Inc.	Dosage unit anion-exchange polymer pharmaceutical compositions
US20090181359A1 (en) *	2007-10-25	2009-07-16	Lou Sheng C	Method of performing ultra-sensitive immunoassays
US20090156647A1 (en)	2007-12-12	2009-06-18	Iovate T. & P. Inc.	Method for maintaining physiological pH levels during intensive physical exercise
PA8807201A1 (es)	2007-12-14	2009-07-23	Genzyme Corp	Composiciones farmaceuticas
US20100316589A1 (en)	2007-12-14	2010-12-16	Hitesh Bhagat	Coated Pharmaceutical Compositions
WO2009097127A1 (en)	2008-01-31	2009-08-06	Genzyme Corporation	Pharmaceutical compositions
CN102307578B (zh)	2008-03-11	2016-05-04	利维昂尼克斯公司	治疗炎症和炎症相关疾病的方法和组合物
CA2720865A1 (en)	2008-04-08	2009-10-15	Usv Limited	Process for preparation of amine polymer salt
US20110112445A1 (en)	2008-04-11	2011-05-12	GP Investmenti S.r.l	Handpiece for Ultrasound Treatments of Human Tissue
US20110142952A1 (en)	2008-06-20	2011-06-16	Harris David J	Pharmaceutical Compositions
DE102008030046A1 (de)	2008-06-25	2009-12-31	Ratiopharm Gmbh	Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en)	2008-07-14	2010-01-14	Glenmark Generics, Ltd.	Tablet compositions of amine polymers
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
WO2010022381A1 (en)	2008-08-22	2010-02-25	Relypsa, Inc.	Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
US8337824B2 (en)	2008-08-22	2012-12-25	Relypsa, Inc.	Linear polyol stabilized polyfluoroacrylate compositions
MX2011002915A (es)	2008-09-25	2011-04-21	Vive Nano Inc	Metodos para producir nanoparticulas polimericas y formulaciones de ingredientes activos.
US20110268666A1 (en)	2008-09-29	2011-11-03	Yissum Research Development Company of the Research University of Jerusalem, Ltd.	Novel gastroretentive delivery system
WO2010059384A1 (en)	2008-10-30	2010-05-27	Janssen Pharmaceutica Nv	Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
US20100166861A1 (en)	2008-12-29	2010-07-01	Kelly Noel Lynch	Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
KR20110119714A (ko)	2009-01-22	2011-11-02	유에스브이 리미티드	포스페이트 결합 폴리머를 포함하는 약학적 조성물
EP2488172A4 (en)	2009-10-13	2014-08-13	Univ Michigan	DENDRIMER COMPOSITION AND METHOD FOR THEIR SYNTHESIS
DK2490675T3 (en)	2009-10-22	2019-04-29	Synthon Bv	Pharmaceutical compositions with sevelamer
WO2011071927A2 (en)	2009-12-07	2011-06-16	Ironwood Pharmaceuticals, Inc.	Treatments for gastrointestinal disorders
GB2490853B (en)	2010-02-24	2018-08-08	Relypsa Inc	Polyimidazoles for use as bile acid sequestrants
KR101822608B1 (ko) *	2010-02-24	2018-01-29	리립사, 인크.	담즙산 격리제로서 사용하기 위한 아민 폴리머
US9181364B2 (en) *	2010-02-24	2015-11-10	Relypsa, Inc.	Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants
RU2417782C1 (ru) *	2010-03-03	2011-05-10	Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия"	Способ лечения ацидоза рубца
IT1406068B1 (it)	2010-07-22	2014-02-06	Medestea Int Spa	Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
CN103314296A (zh) *	2010-08-10	2013-09-18	安姆根有限公司	用于检测针对靶抗体的中和抗体的双功能体外靶结合测定
US20130156720A1 (en)	2010-08-27	2013-06-20	Ironwood Pharmaceuticals, Inc.	Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR101238210B1 (ko)	2011-06-30	2013-03-04	엘지전자 주식회사	이동 단말기
US20130137772A1 (en)	2011-11-29	2013-05-30	Raymond J. Bergeron	Hydroxypolyamine salts
ES2796254T3 (es)	2012-06-21	2020-11-26	Keryx Biopharmaceuticals Inc	Uso de citrato férrico en el tratamiento de pacientes con enfermedad renal crónica
KR20210005314A (ko)	2012-10-08	2021-01-13	리립사, 인크.	고혈압 및 고칼륨혈증을 치료하기 위한 칼륨-결합제
JP6453860B2 (ja)	2013-06-05	2019-01-16	トリシダ・インコーポレイテッドＴｒｉｃｉｄａ，Ｉｎｃ．	経口投与用プロトン結合ポリマー
US20160256486A1 (en)	2013-11-04	2016-09-08	Keryx Biopharmaceuticals, Inc.	Use of ferric citrate in the treatment of and the reduction of mortality and morbidity related to adverse cardiac events in chronic kidney disease patients
ME03783B (me)	2014-12-10	2021-04-20	Tricida Inc	Polimeri koji vezuju protone za oralnu primjenu
MA44875A (fr)	2016-05-06	2019-03-13	Tricida Inc	Compositions pour le traitement de troubles acido-basiques
WO2019090177A1 (en)	2017-11-03	2019-05-09	Tricida, Inc.	Method of treating acid-base disorders
EP3703706A4 (en)	2017-11-03	2022-04-27	Tricida Inc.	COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-BASED DISORDERS
WO2019236124A1 (en)	2018-06-04	2019-12-12	Tricida, Inc.	Method of treating acid-base disorders
MA51628A (fr)	2018-06-04	2021-03-17	Tricida Inc	Méthode de traitement de troubles de l'équilibre acido-basique
WO2019236639A1 (en)	2018-06-04	2019-12-12	Tricida, Inc.	Method of treating acid-base disorders

2014
- 2014-06-05 JP JP2016518006A patent/JP6453860B2/ja active Active
- 2014-06-05 PL PL17177221T patent/PL3287133T3/pl unknown
- 2014-06-05 LT LTEP17177221.3T patent/LT3287133T/lt unknown
- 2014-06-05 SM SM20200596T patent/SMT202000596T1/it unknown
- 2014-06-05 MX MX2015016527A patent/MX364785B/es active IP Right Grant
- 2014-06-05 EP EP17177221.3A patent/EP3287133B1/en active Active
- 2014-06-05 KR KR1020247003745A patent/KR102717667B1/ko active Active
- 2014-06-05 LT LTEP14742001.2T patent/LT3003327T/lt unknown
- 2014-06-05 HU HUE14742001A patent/HUE034836T2/en unknown
- 2014-06-05 HU HUE17177221A patent/HUE043999T2/hu unknown
- 2014-06-05 RS RS20190806A patent/RS59033B1/sr unknown
- 2014-06-05 EP EP19169259.9A patent/EP3578185B1/en active Active
- 2014-06-05 SI SI201431698T patent/SI3578185T1/sl unknown
- 2014-06-05 SM SM20190391T patent/SMT201900391T1/it unknown
- 2014-06-05 HU HUE19169259A patent/HUE051198T2/hu unknown
- 2014-06-05 RS RS20201307A patent/RS61005B1/sr unknown
- 2014-06-05 ES ES19169259T patent/ES2834485T3/es active Active
- 2014-06-05 ES ES14742001.2T patent/ES2646271T3/es active Active
- 2014-06-05 PL PL14742001T patent/PL3003327T3/pl unknown
- 2014-06-05 ES ES17177221T patent/ES2733493T3/es active Active
- 2014-06-05 DK DK17177221.3T patent/DK3287133T3/da active
- 2014-06-05 DK DK14742001.2T patent/DK3003327T3/en active
- 2014-06-05 RU RU2015155596A patent/RU2728778C2/ru active
- 2014-06-05 SI SI201430466T patent/SI3003327T1/en unknown
- 2014-06-05 PT PT191692599T patent/PT3578185T/pt unknown
- 2014-06-05 CN CN202010780603.3A patent/CN111671766B/zh active Active
- 2014-06-05 HR HRP20171590TT patent/HRP20171590T1/hr unknown
- 2014-06-05 EP EP14742001.2A patent/EP3003327B1/en active Active
- 2014-06-05 EP EP20183421.5A patent/EP3812761B1/en active Active
- 2014-06-05 TR TR2019/09355T patent/TR201909355T4/tr unknown
- 2014-06-05 PT PT147420012T patent/PT3003327T/pt unknown
- 2014-06-05 CA CA2912911A patent/CA2912911C/en active Active
- 2014-06-05 DK DK19169259.9T patent/DK3578185T3/da active
- 2014-06-05 PT PT17177221T patent/PT3287133T/pt unknown
- 2014-06-05 BR BR112015030142-8A patent/BR112015030142B1/pt active IP Right Grant
- 2014-06-05 KR KR1020237024806A patent/KR102633597B1/ko active Active
- 2014-06-05 KR KR1020247033799A patent/KR20240152425A/ko active Pending
- 2014-06-05 MX MX2019005300A patent/MX387845B/es unknown
- 2014-06-05 WO PCT/US2014/041152 patent/WO2014197725A1/en not_active Ceased
- 2014-06-05 LT LTEP19169259.9T patent/LT3578185T/lt unknown
- 2014-06-05 CN CN202010780604.8A patent/CN111671767B/zh active Active
- 2014-06-05 KR KR1020217034420A patent/KR20210131457A/ko not_active Ceased
- 2014-06-05 SI SI201431241T patent/SI3287133T1/sl unknown
- 2014-06-05 KR KR1020157036999A patent/KR102318910B1/ko active Active
- 2014-06-05 CN CN201480032395.1A patent/CN105377270B/zh active Active
- 2014-06-05 AU AU2014274817A patent/AU2014274817B2/en active Active
- 2014-06-23 US US14/311,852 patent/US9205107B2/en active Active
2015
- 2015-01-27 NO NO15000230A patent/NO2905572T3/no unknown
- 2015-11-18 US US14/944,844 patent/US9925214B2/en active Active
- 2015-11-24 IL IL242758A patent/IL242758B/en active IP Right Grant
- 2015-12-01 MX MX2021013880A patent/MX2021013880A/es unknown
2017
- 2017-09-26 US US15/715,934 patent/US9993500B2/en active Active
- 2017-11-06 CY CY20171101159T patent/CY1119611T1/el unknown
2018
- 2018-06-07 US US16/002,269 patent/US10363268B2/en active Active
- 2018-06-07 US US16/002,306 patent/US10391118B2/en active Active
- 2018-08-16 HK HK18110550.1A patent/HK1251151B/en unknown
- 2018-12-13 JP JP2018233254A patent/JP6759316B2/ja active Active
2019
- 2019-04-04 US US16/375,843 patent/US10369169B1/en active Active
- 2019-06-14 HR HRP20191074TT patent/HRP20191074T1/hr unknown
- 2019-07-04 CY CY20191100694T patent/CY1121801T1/el unknown
- 2019-08-16 US US16/542,969 patent/US11197887B2/en active Active
- 2019-08-22 AU AU2019219800A patent/AU2019219800B1/en active Active
- 2019-12-04 AU AU2019275584A patent/AU2019275584B2/en active Active
2020
- 2020-01-09 IL IL271932A patent/IL271932B/en active IP Right Grant
- 2020-09-02 JP JP2020147224A patent/JP7075455B2/ja active Active
- 2020-10-20 IL IL278183A patent/IL278183B/en unknown
- 2020-10-30 CY CY20201101028T patent/CY1123673T1/el unknown
- 2020-11-02 HR HRP20201767TT patent/HRP20201767T1/hr unknown
2021
- 2021-12-09 US US17/546,339 patent/US20220096534A1/en active Pending
2022
- 2022-05-13 JP JP2022079329A patent/JP7588871B2/ja active Active
2024
- 2024-11-06 JP JP2024194308A patent/JP2025024009A/ja active Pending

Also Published As

Publication number	Publication date
CY1121801T1 (el)	2020-07-31
JP7075455B2 (ja)	2022-05-25
US10363268B2 (en)	2019-07-30
AU2019275584B2 (en)	2021-10-21
MX2015016527A (es)	2016-07-22
LT3003327T (lt)	2017-12-27
KR20240023672A (ko)	2024-02-22
WO2014197725A1 (en)	2014-12-11
JP7588871B2 (ja)	2024-11-25
AU2019219800B1 (en)	2019-09-19
CY1123673T1 (el)	2022-03-24
LT3578185T (lt)	2020-11-25
US10369169B1 (en)	2019-08-06
HUE043999T2 (hu)	2019-09-30
JP2019065024A (ja)	2019-04-25
JP2016520652A (ja)	2016-07-14
US20180280428A1 (en)	2018-10-04
US20190134075A1 (en)	2019-05-09
KR20160041855A (ko)	2016-04-18
EP3578185B1 (en)	2020-08-05
US11197887B2 (en)	2021-12-14
EP3578185A1 (en)	2019-12-11
CA2912911A1 (en)	2014-12-11
BR112015030142A2 (pt)	2017-07-25
BR112015030142B1 (pt)	2023-03-07
MX2019005300A (es)	2019-08-12
RU2015155596A3 (pt)	2018-05-10
CA2912911C (en)	2023-10-03
ES2646271T3 (es)	2017-12-13
LT3287133T (lt)	2019-07-10
US20220096534A1 (en)	2022-03-31
HUE034836T2 (en)	2018-03-28
KR20240152425A (ko)	2024-10-21
KR102318910B1 (ko)	2021-10-29
MX2021013880A (es)	2022-06-02
EP3287133B1 (en)	2019-04-17
ES2733493T3 (es)	2019-11-29
IL278183A (en)	2020-11-30
US9925214B2 (en)	2018-03-27
DK3578185T3 (da)	2020-11-02
CN111671767B (zh)	2024-03-08
RS59033B1 (sr)	2019-08-30
PT3287133T (pt)	2019-07-12
CY1119611T1 (el)	2018-04-04
AU2014274817B2 (en)	2019-05-23
SI3003327T1 (en)	2018-01-31
US9993500B2 (en)	2018-06-12
PL3287133T3 (pl)	2019-10-31
CN111671767A (zh)	2020-09-18
EP3287133A1 (en)	2018-02-28
US20190231812A1 (en)	2019-08-01
NO2905572T3 (pt)	2017-12-16
PT3578185T (pt)	2020-11-10
DK3287133T3 (da)	2019-07-01
MX387845B (es)	2025-03-19
RU2015155596A (ru)	2017-07-18
ES2834485T3 (es)	2021-06-17
SMT201900391T1 (it)	2019-09-09
EP3812761A1 (en)	2021-04-28
US20150056451A1 (en)	2015-02-26
HK1223288A1 (en)	2017-07-28
HK1222120A1 (zh)	2017-06-23
HK1251151B (en)	2020-04-24
HUE051198T2 (hu)	2021-03-01
JP2020203917A (ja)	2020-12-24
DK3003327T3 (en)	2017-10-23
SI3287133T1 (sl)	2019-09-30
JP2022107004A (ja)	2022-07-20
IL271932A (en)	2020-02-27
KR20230114326A (ko)	2023-08-01
KR102633597B1 (ko)	2024-02-06
EP3003327A1 (en)	2016-04-13
US10391118B2 (en)	2019-08-27
RS61005B1 (sr)	2020-11-30
HRP20201767T1 (hr)	2020-12-25
SI3578185T1 (sl)	2021-01-29
CN111671766A (zh)	2020-09-18
KR102717667B1 (ko)	2024-10-16
AU2019275584A1 (en)	2020-01-02
RU2728778C2 (ru)	2020-07-31
EP3003327B1 (en)	2017-08-09
JP6759316B2 (ja)	2020-09-23
MX364785B (es)	2019-05-07
IL271932B (en)	2020-11-30
US20160074430A1 (en)	2016-03-17
US9205107B2 (en)	2015-12-08
EP3812761B1 (en)	2025-12-24
IL278183B (en)	2021-09-30
US20200206260A1 (en)	2020-07-02
CN105377270A (zh)	2016-03-02
AU2014274817A1 (en)	2015-12-24
US20180015121A1 (en)	2018-01-18
CN111671766B (zh)	2024-03-08
PL3003327T3 (pl)	2018-02-28
IL242758B (en)	2020-01-30
TR201909355T4 (tr)	2019-07-22
HRP20171590T1 (hr)	2017-12-29
JP6453860B2 (ja)	2019-01-16
KR20210131457A (ko)	2021-11-02
SMT202000596T1 (it)	2021-01-05
HRP20191074T1 (hr)	2019-09-20
JP2025024009A (ja)	2025-02-19
CN105377270B (zh)	2020-09-04

Publication	Publication Date	Title
IL278183A (en)	2020-11-30	Proton-binding polymers for oral administration
IL246377A0 (en)	2016-08-31	Pharmaceutical preparations for oral administration
IL240846A0 (en)	2015-10-29	drug combination
IL278034B (en)	2022-04-01	Proton binding polymers for oral administration
EP2974719A4 (en)	2016-08-03	PHARMACEUTICAL COMBINED MEDICINE
ZA201600027B (en)	2018-07-25	Pharmaceutical preparation
GB201305103D0 (en)	2013-05-01	An oral dosage form
GB2520315B (en)	2017-12-06	Oral Syringes
ZA201506465B (en)	2021-06-30	Pharmaceutical preparation
GB201309971D0 (en)	2013-07-17	Oral medicines syringe
GB201316662D0 (en)	2013-11-06	Pharmaceutical Combination
GB201320786D0 (en)	2014-01-08	Medicament